D.B. Root & Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-4,011
| Closed | -$350K | – | 185 |
|
2024
Q1 | $350K | Hold |
4,011
| – | – | 0.12% | 139 |
|
2023
Q4 | $387K | Sell |
4,011
-395
| -9% | -$38.1K | 0.14% | 127 |
|
2023
Q3 | $390K | Buy |
4,406
+33
| +0.8% | +$2.92K | 0.15% | 123 |
|
2023
Q2 | $379K | Buy |
4,373
+290
| +7% | +$25.1K | 0.14% | 133 |
|
2023
Q1 | $397K | Buy |
4,083
+1
| +0% | +$97 | 0.16% | 122 |
|
2022
Q4 | $422K | Sell |
4,082
-299
| -7% | -$30.9K | 0.18% | 115 |
|
2022
Q3 | $371K | Sell |
4,381
-7
| -0.2% | -$593 | 0.17% | 116 |
|
2022
Q2 | $363K | Sell |
4,388
-3,223
| -42% | -$267K | 0.16% | 128 |
|
2022
Q1 | $586K | Buy |
7,611
+34
| +0.4% | +$2.62K | 0.22% | 111 |
|
2021
Q4 | $669K | Sell |
7,577
-152
| -2% | -$13.4K | 0.24% | 106 |
|
2021
Q3 | $597K | Sell |
7,729
-1,521
| -16% | -$117K | 0.23% | 110 |
|
2021
Q2 | $771K | Sell |
9,250
-82
| -0.9% | -$6.84K | 0.29% | 96 |
|
2021
Q1 | $704K | Buy |
9,332
+2,336
| +33% | +$176K | 0.28% | 96 |
|
2020
Q4 | $613K | Sell |
6,996
-26
| -0.4% | -$2.28K | 0.24% | 105 |
|
2020
Q3 | $534K | Buy |
7,022
+783
| +13% | +$59.5K | 0.21% | 122 |
|
2020
Q2 | $769K | Sell |
6,239
-220
| -3% | -$27.1K | 0.33% | 81 |
|
2020
Q1 | $545K | Buy |
6,459
+275
| +4% | +$23.2K | 0.28% | 92 |
|
2019
Q4 | $522K | Buy |
6,184
+2,260
| +58% | +$191K | 0.23% | 120 |
|
2019
Q3 | $264K | Sell |
3,924
-175
| -4% | -$11.8K | 0.12% | 171 |
|
2019
Q2 | $351K | Sell |
4,099
-45
| -1% | -$3.85K | 0.16% | 155 |
|
2019
Q1 | $368K | Buy |
4,144
+394
| +11% | +$35K | 0.16% | 150 |
|
2018
Q4 | $319K | Sell |
3,750
-2,800
| -43% | -$238K | 0.16% | 147 |
|
2018
Q3 | $635K | Sell |
6,550
-2,110
| -24% | -$205K | 0.28% | 108 |
|
2018
Q2 | $816K | Buy |
8,660
+345
| +4% | +$32.5K | 0.39% | 91 |
|
2018
Q1 | $674K | Buy |
+8,315
| New | +$674K | 0.36% | 96 |
|